aniracetam has been researched along with Bewilderment in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-four patients with senile dementia of the Alzheimer type were randomly allocated into double-blind treatment with either aniracetam (RO 13-5057) 1 g or placebo daily for 3 months." | 2.66 | Senile dementia of the Alzheimer type treated with aniracetam: a new nootropic agent. ( Lahdes, A; Mölsä, P; Portin, R; Rinne, UK; Sourander, LB, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sourander, LB | 1 |
| Portin, R | 1 |
| Mölsä, P | 1 |
| Lahdes, A | 1 |
| Rinne, UK | 1 |
1 trial available for aniracetam and Bewilderment
| Article | Year |
|---|---|
Senile dementia of the Alzheimer type treated with aniracetam: a new nootropic agent.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Confusion; Double-Blind Method; Humans; Neuropsyc | 1987 |